CACNA1G/Cav3.1 Blocking Peptide (#BLP-CC021) is the original antigen used for immunization during Anti-CACNA1G (CaV3.1) Antibody (#ACC-021) generation. The blocking peptide binds and ‘blocks’ Anti-CACNA1G/Cav3.1 primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of rat brain membranes:
- Expression of CACNA1G in rat cerebellumImmunohistochemical staining of rat cerebellum using Anti-CACNA1G (CaV3.1) Antibody (#ACC-021). A. CACNA1G immunoreactivity (green) appears in the molecular layer. B. Nuclear staining using DAPI as the counterstain (blue). C. Merged images A and B. Mol = molecular layer.
- Human myometrium (1:200) (Blanks, A.M. et al. (2007) J. Physiol. 581, 915.).
- MDEEEDGAGAEESGQPRSFTQL(C), corresponding to amino acid residues 1-22 of rat CACNA1G (Accession O54898).